Our story began in San Antonio – where eRapa was originally invented at the University of Texas and funded in part by grants from the Cancer ...
News
- Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment ...
- Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment ...
We thank the scientists, clinicians, investors and biotech executives ... eRapaTM was originally developed at University of Texas Health San Antonio ...
- Device for detecting retinal disease takes top prize in UTSA's spring Tech Symposium
The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community ...
- Range of city charter proposals include council raises and uncapped city manager pay
Bioscience-Medicine · Border & Immigration ... Bioscience-Medicine ... Members of the San Antonio Charter Review Commission listen to a presentation from ...
- Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering
Contacts: Investors and Media Scilex Holding Company 960 San Antonio Road ... Biotech Bay · Biotech Beach · BioCapital · BioMidwest · Bio NC · BioForest ...